Caliper Q2 Revenues Jump 20 Percent on Strong Contract Revenue | GenomeWeb
NEW YORK (GenomeWeb News) – Caliper Life Sciences said today that second-quarter revenues increased 20 percent and net loss declined 51 percent on strong contract revenues.
 
Receipts for the second quarter increased to $24.3 million from $20.3 million in the same quarter last year.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.